News

Jazz Pharma has agreed to pay $145 million to settle lawsuits claiming it illegally acted to prevent generic versions of its ...
Jazz is being accused of anti-competitive practices regarding its narcolepsy drug, as generic competitors emerge on the ...
Jazz Pharmaceuticals said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem. Xyrem, a medication approved in ...
Analysts at BMO Capital Markets said Centessa’s orexin receptor agonist has “best-in-class” potential for narcolepsy, putting ...
Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.
Healthcare Analysts, along with Dr. Kiran Maski discuss Narcolepsy on an Analyst/Industry conference call to be held on April 11 at 11 am. Stay ...
Explore more
People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...
Multiple sleep disorders can affect your energy levels, and two that often get confused for one another are narcolepsy and chronic fatigue syndrome. Though both chronic fatigue syndrome and ...
Narcolepsy is a nervous system disorder that involves your brain. You struggle to manage sleep patterns and stay awake. No matter how much rest you got the night before, an intense urge to sleep ...
Centessa Pharmaceuticals plc shifts focus to ORX750 for sleep disorders after discontinuing SerpinPC. Click here to find out ...
There are many different types of sleep disorders, which can lead to additional symptoms and issues like increased depression and anxiety, difficulty focusing and even diabetes or heart disease. Below ...